Clinical Features and Treatment Results in Children With Head and Neck Rhabdomyosarcoma

Area of Science:

• Pediatric Oncology
• Cancer Research
• Head and Neck Surgery

Background:

• Rhabdomyosarcoma (RMS) is a significant pediatric cancer, with head and neck locations being common.
• Head and neck RMS presents unique challenges in diagnosis and treatment for children.

Purpose of the Study:

• To analyze clinical features and treatment outcomes of pediatric head and neck RMS.
• To identify prognostic factors influencing survival in this patient cohort.

Main Methods:

• Retrospective review of 65 children diagnosed with head and neck RMS between 2004 and 2018.
• Analysis of tumor location, histopathology, chemotherapy regimens, and survival data.

Main Results:

• Parameningeal location (49.2%) and embryonal subtype (73.8%) were most common.
• Overall 5-year event-free survival (EFS) was 41.2%, and overall survival (OS) was 59.3%.
• Parameningeal RMS showed significantly poorer prognosis (5-year OS 34.2%) compared to orbital (85.2%) or other nonparameningeal sites (80%).

Conclusions:

• Tumor location, risk grouping, and stage are critical prognostic indicators in pediatric head and neck RMS.
• Parameningeal location and advanced stage are associated with poor outcomes.
• Novel therapeutic approaches are crucial to improve survival rates, especially for high-risk groups.